Europe approves new drug that can fix faulty genes

The idea of treating genetic diseases by replacing a defective gene with a working copy has been around for nearly three decades, but the road to creating an actual therapy that's safe and effective has proven to be a long and difficult one. Now, thanks to the efforts of the Dutch biotech company uniQure, the Western… »11/05/12 5:04pm11/05/12 5:04pm